TY - JOUR
T1 - Frequency of Orthostatic Hypotension in Isolated REM Sleep Behavior Disorder
T2 - The North American Prodromal Synucleinopathy Cohort
AU - Elliott, Jonathan E.
AU - Bryant-Ekstrand, Mohini D.
AU - Keil, Allison T.
AU - Ligman, Brittany R.
AU - Lim, Miranda M.
AU - Zitser, Jennifer
AU - During, Emmanuel H.
AU - Gagnon, Jean Francois
AU - St Louis, Erik K.
AU - Fields, Julie A.
AU - Huddleston, Daniel E.
AU - Bliwise, Donald L.
AU - Avidan, Alon Y.
AU - Schenck, Carlos H.
AU - McLeland, Jennifer
AU - Criswell, Susan R.
AU - Davis, Albert A.
AU - Videnovic, Aleksandar
AU - Lee-Iannotti, Joyce K.
AU - Postuma, Ronald
AU - Boeve, Bradley F.
AU - Ju, Yo El S.
AU - Miglis, Mitchell G.
AU - Choudhury, Parichita
AU - Forsberg, Leah K.
AU - Howell, Michael J.
AU - Shprecher, David R.
AU - Amudson-Huffmaster, Sommer
AU - Arik, Anam
AU - Brushaber, Nellie
AU - Chung, Jae Woo
AU - De Kam, Joshua
AU - Ekelmans, Adrian
AU - Fischbach, Ellen
AU - Keane, Marissa
AU - Kraft, Ruth
AU - MacKinnon, Colum
AU - Miner-Rose, Daeva
AU - Murphy, Samantha
AU - Olivo, Cosette
AU - Pelletier, Amelie
AU - Powers, Katherine L.M.
AU - Rivera, Adreanne M.
AU - Sanchez, Sarahmay
AU - Stauder, Matthew
AU - Summers, Rebekah
AU - Taylor, Leah
AU - Tiegan, Luke
AU - Timm, Paul
AU - Tucker, Kelsey A.
AU - Tran, Peter
AU - Galasko, Douglas
AU - Mignot, Emmanuel
N1 - Publisher Copyright:
© American Academy of Neurology.
PY - 2023/12/12
Y1 - 2023/12/12
N2 - Background and ObjectivesAlthough orthostatic hypotension (OH) can be an early feature of autonomic dysfunction in isolated REM sleep behavior disorder (iRBD), no large-scale studies have examined the frequency of OH in iRBD. In this study, we prospectively evaluated the frequency of OH in a large multicenter iRBD cohort.MethodsParticipants 18 years or older with video polysomnogram-confirmed iRBD were enrolled through the North American Prodromal Synucleinopathy consortium. All participants underwent 3-minute orthostatic stand testing to assess the frequency of OH, and a Δ heart rate/Δ systolic blood pressure (ΔHR/ΔSBP) ratio <0.5 was used to define reduced HR augmentation, suggestive of neurogenic OH. All participants completed a battery of assessments, including the Scales for Outcomes in Parkinson Disease-Autonomic Dysfunction (SCOPA-AUT) and others assessing cognitive, motor, psychiatric, and sensory domains.ResultsOf 340 iRBD participants (65 ± 10 years, 82% male), 93 (27%) met criteria for OH (ΔHR/ΔSBP 0.37 ± 0.28; range 0.0-1.57), and of these, 72 (77%) met criteria for OH with reduced HR augmentation (ΔHR/ΔSBP 0.28 ± 0.21; range 0.0-0.5). Supine hypertension (sHTN) was present in 72% of those with OH. Compared with iRBD participants without OH, those with OH were older, reported older age of RBD symptom onset, and had worse olfaction. There was no difference in autonomic symptom scores as measured by SCOPA-AUT.DiscussionOH and sHTN are common in iRBD. However, as patients may have reduced autonomic symptom awareness, orthostatic stand testing should be considered in clinical evaluations. Longitudinal studies are needed to clarify the relationship between OH and phenoconversion risk in iRBD.Trial Registration InformationClinicalTrials.gov: NCT03623672; North American Prodromal Synucleinopathy Consortium.
AB - Background and ObjectivesAlthough orthostatic hypotension (OH) can be an early feature of autonomic dysfunction in isolated REM sleep behavior disorder (iRBD), no large-scale studies have examined the frequency of OH in iRBD. In this study, we prospectively evaluated the frequency of OH in a large multicenter iRBD cohort.MethodsParticipants 18 years or older with video polysomnogram-confirmed iRBD were enrolled through the North American Prodromal Synucleinopathy consortium. All participants underwent 3-minute orthostatic stand testing to assess the frequency of OH, and a Δ heart rate/Δ systolic blood pressure (ΔHR/ΔSBP) ratio <0.5 was used to define reduced HR augmentation, suggestive of neurogenic OH. All participants completed a battery of assessments, including the Scales for Outcomes in Parkinson Disease-Autonomic Dysfunction (SCOPA-AUT) and others assessing cognitive, motor, psychiatric, and sensory domains.ResultsOf 340 iRBD participants (65 ± 10 years, 82% male), 93 (27%) met criteria for OH (ΔHR/ΔSBP 0.37 ± 0.28; range 0.0-1.57), and of these, 72 (77%) met criteria for OH with reduced HR augmentation (ΔHR/ΔSBP 0.28 ± 0.21; range 0.0-0.5). Supine hypertension (sHTN) was present in 72% of those with OH. Compared with iRBD participants without OH, those with OH were older, reported older age of RBD symptom onset, and had worse olfaction. There was no difference in autonomic symptom scores as measured by SCOPA-AUT.DiscussionOH and sHTN are common in iRBD. However, as patients may have reduced autonomic symptom awareness, orthostatic stand testing should be considered in clinical evaluations. Longitudinal studies are needed to clarify the relationship between OH and phenoconversion risk in iRBD.Trial Registration InformationClinicalTrials.gov: NCT03623672; North American Prodromal Synucleinopathy Consortium.
UR - http://www.scopus.com/inward/record.url?scp=85180108633&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85180108633&partnerID=8YFLogxK
U2 - 10.1212/WNL.0000000000207883
DO - 10.1212/WNL.0000000000207883
M3 - Article
C2 - 37857496
AN - SCOPUS:85180108633
SN - 0028-3878
VL - 101
SP - E2545-E2559
JO - Neurology
JF - Neurology
IS - 24
ER -